A detailed history of Balyasny Asset Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 194,764 shares of OGN stock, worth $4.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
194,764
Previous 331,096 41.18%
Holding current value
$4.03 Million
Previous $4.77 Million 23.31%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $1.88 Million - $2.56 Million
-136,332 Reduced 41.18%
194,764 $3.66 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $1.4 Million - $2.22 Million
-128,071 Reduced 27.89%
331,096 $4.77 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $17.3 Million - $24.9 Million
-1,045,746 Reduced 69.49%
459,167 $7.97 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $15 Million - $19.2 Million
-779,278 Reduced 34.12%
1,504,913 $31.3 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $25.7 Million - $38.4 Million
1,197,979 Added 110.29%
2,284,191 $53.7 Million
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $5.55 Million - $6.81 Million
-238,090 Reduced 17.98%
1,086,212 $30.3 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $25.5 Million - $37.3 Million
1,089,533 Added 464.09%
1,324,302 $31 Million
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $7.43 Million - $9.13 Million
234,769 New
234,769 $7.92 Million
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $29.5 Million - $38.1 Million
-967,268 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $19.9 Million - $25.7 Million
693,221 Added 252.96%
967,268 $29.5 Million
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $6.19 Million - $7.71 Million
-216,235 Reduced 44.1%
274,047 $8.99 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $13.9 Million - $18.6 Million
490,282 New
490,282 $14.8 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.26B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.